Search

Your search keyword '"Waters, David"' showing total 2,418 results

Search Constraints

Start Over You searched for: Author "Waters, David" Remove constraint Author: "Waters, David"
2,418 results on '"Waters, David"'

Search Results

1. Mineral Detection of Neutrinos and Dark Matter 2024. Proceedings

5. Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

6. Determination of the Helpfulness of Physics Exam Study Methods

9. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

11. Determination of the Helpfulness of Physics Exam Study Methods

14. Determination of the helpfulness of physics exam study methods

15. Gender Bias in Student Evaluations of Teaching: 'Punish[ing] Those Who Fail to Do Their Gender Right'

16. The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohorts.

17. Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.

18. Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

19. Myocardial Infarction in the ISCHEMIA Trial

21. Impact of Complete Revascularization in the ISCHEMIA Trial

22. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

23. Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?

24. Investigating students seriousness during selected conceptual inventory surveys

26. Notes From Cardiology Clinic: Brittle Bones and Blue Sclerae

27. Notes From the Cardiology Clinic: Facing Down the Dragons of Health Anxiety

28. When Diastole Lets You Down: Clinical Relevance of a Widened Pulse Pressure

29. Notes From Cardiology Clinic: The Patients We Dislike

30. Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib

32. HIV infection and coronary heart disease: mechanisms and management

33. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

34. Notes From Cardiology Clinic: Woman, Lost During Follow-up

36. Gender Bias in Student Evaluations of Teaching: 'Punish[ing] Those Who Fail To Do Their Gender Right'

37. Improving Statin Noncompliance: If You Build It, Will They Come?

38. Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials

39. Cholesterol Lowering Guidelines: From Whence We Came and Where We Are Now

40. High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)

41. Lipid Abnormalities in Persons Living With HIV Infection

42. Introduction to Cardiovascular Issues in HIV

43. Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus

44. Comparison of Cranial Cruciate Ligament Rupture Incidence among Parous and Nulliparous Rottweiler Bitches: Evidence from a Lifetime Cohort Study Supporting a Paradigm of Pregnancy-Associated Protection against Subsequent Non-Reproductive Disease Outcomes.

45. Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor

46. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

47. RE: Praluent (Alirocumab)-Induced Renal Injury

48. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events

49. Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin

50. Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk

Catalog

Books, media, physical & digital resources